title: Letter: new treatments for hepatitis C have implications for quality of life in people who inject drug--authors' reply.
authors.affiliation: Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA.|Center for Outcomes Research, Washington, DC, USA.
authors.forename: M
authors.initials: M
authors.lastname: Stepanova
authors.affiliation: Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA. zobair.younossi@inova.org.|Department of Medicine, Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA, USA. zobair.younossi@inova.org.
authors.forename: Z
authors.initials: Z
authors.lastname: Younossi
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D008297:Male; D012254:Ribavirin / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons